These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1981435)

  • 21. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V; Legallou F; Richet H; Dreno B
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW; Gloor M; Dietz P; Höffler U
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H; Kurokawa I; Nishijima S; Asada Y
    Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract]   [Full Text] [Related]  

  • 28. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M; Lamerz A; Franke-Hoffman M
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propionibacterium acnes resistance: a worldwide problem.
    Eady EA; Gloor M; Leyden JJ
    Dermatology; 2003; 206(1):54-6. PubMed ID: 12566805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.
    Marino C; Stoughton RB
    J Am Acad Dermatol; 1982 May; 6(5):902-8. PubMed ID: 6212602
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic sensitivity of comedonal Propionibacterium acnes.
    Guin JD; Huber DS; Gielerak PL
    Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety.
    Arch Dermatol; 1975 Dec; 111(12):1630-6. PubMed ID: 128326
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
    Biswal I; Gaind R; Kumar N; Mohanty S; Manchanda V; Khunger N; V R; Deb M
    J Infect Dev Ctries; 2016 Oct; 10(10):1140-1145. PubMed ID: 27801379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation in acne vulgaris: consumption of complement by comedones.
    Webster GF; Leyden JJ; Nilsson UR
    Infect Immun; 1979 Oct; 26(1):183-6. PubMed ID: 159261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.